Navigation Links
Soligenix Announces Pricing of Public Offering of Common Stock and Warrants
Date:6/21/2013

PRINCETON, N.J., June 21, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) ("Soligenix" or the "Company"), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today the pricing of a registered public offering of shares of common stock and warrants to purchase common stock.

In connection with the public offering, the Company has entered into definitive agreements with institutional investors and certain members of the Company's management and Board of Directors to sell approximately $7.0 million of the Company's securities, consisting of an aggregate of approximately 6.6 million shares of common stock at a price per share of $1.05 and 5-year warrants to purchase up to approximately 5.0 million shares of common stock with an exercise price of $1.65 per share.

Institutional investors in the offering include, among others, an affiliated fund of Third Security, LLC ("Third Security"), a venture capital firm founded by R.J. Kirk.  In connection with Third Security's investment in the Company, the Company intends to appoint a Third Security designee to the Board of Soligenix.

The Company plans to use the net proceeds from the offering to further develop its product candidates and for general working capital purposes.

Soligenix's two lead product candidates include a proprietary formulation of oral BDP (beclomethasone 17,21-dipropionate) for pediatric Crohn's disease (SGX203), which is currently in a Phase 1 clinical trial, and a novel innate defense regulator (IDR) technology for the treatment of oral Mucositis (SGX942) for which the Company plans to initiate a Phase 2 clinical trial in the second half of 2013.

Maxim Group LLC served as placement agent for the offering.

The securities described above were offered
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Grants Soligenix "Fast Track" Designation for SGX942 for the Treatment of Oral Mucositis in Patients with Head and Neck Cancer
2. Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohns Disease
3. Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
4. Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
5. Soligenix to Present at World Vaccine Congress & Expo
6. Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
7. Soligenix to Present at 15th Annual BIO CEO & Investor Conference
8. Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
9. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
10. Soligenix Reports Third Quarter 2012 Financial Results and Highlights Recent Accomplishments
11. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015  The quality function within the medical ... meet quality standards at every stage of the product ... leaders also have the challenge of balancing quality and ... who don,t effectively balance these priorities risk funding and ... failure and regulatory scrutiny. For the third ...
(Date:3/27/2015)... , March 27, 2015 Levi & ... Pharmaceutical, Inc. (NASDAQ: OHRP ) concerning possible violations ... issued by the Company in connection with its study ... TO: http://zlk.9nl.com/ohr-pharmaceutical-ohrp or contact Joseph E. ... or by telephone at (212) 363-7500, toll-free: (877) ...
(Date:3/27/2015)... March 27, 2015 /PRNewswire/ - Medicure Inc. (the "Company") ... has approved the grant of an aggregate of 236,070 ... and consultants of the Company pursuant to the Company,s ... to expire on the tenth anniversary of the date ... third anniversary of the date of grant and 50,000 ...
Breaking Medicine Technology:New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2
... Pa., July 28, 2011 Kensey Nash Corporation (Nasdaq: ... earnings results for its fourth quarter and fiscal year ended ... August 18, 2011.   Joe Kaufmann, President and ... on Thursday, August 18, 2011 at 9:00 A.M. Eastern Time. ...
... 2011 Questcor Pharmaceuticals, Inc. (NASDAQ:  QCOR) announced today that ... to be held August 9-11, 2011 at the InterContinental Boston ... Officer, is scheduled to present an overview of the Company ... To listen to the audio web cast of ...
Cached Medicine Technology:Kensey Nash Corporation Announces Its Fourth Quarter and Fiscal Year End 2011 Earnings Release Date and Teleconference 2Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011 2
(Date:3/29/2015)... “Health is an endo thing, from within,” opened ... the cannabinoid system … we learn it’s where health ... Update ~ new on the Bryan William Brickner ... The Cannabis Papers: A citizen’s guide to cannabinoids (2011), ... system (CS) articles discussing: cannabinoids in the treatment of ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Take a ... system kicks into action. Acids tumble into the stomach, ... a faulty valve-like structure lets these acids run amok, ... an extremely common symptom. More than 60 million Americans ... slides examine where heartburn starts, and how it can ...
(Date:3/28/2015)... March 28, 2015 India Network ... is made available to all visitors who purchase the ... All members are encouraged to purchase the insurance program ... lack of proper coverage for pre-existing medical conditions. Parents ... or two medical conditions with serious consequences to their ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 How ... is a growing field in orthopaedic medicine. While diagnostic ... tear to confirm the pain etiology, research presented today ... AOSSM ) Specialty Day suggests that pain relief from ... arthroscopic hip surgery. , “Our study looked to ...
(Date:3/28/2015)... March 28, 2015 Lately the ... regarding recent changes and proposals around the NCAA. In ... and former collegiate student-athletes across a spectrum of universities ... on common challenges. The special panel consists of athletes ... sports ranging from football, track and field, baseball, and ...
Breaking Medicine News(10 mins):Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3
... world-leading publisher of medical information products and services, announced ... (PUMP) it has donated over 5,000 books to medical ... is supported by the Development Centre for Medical Science ... is in line with the spirit of the healthcare ...
... difference, report finds , THURSDAY, Oct. 8 (HealthDay News) -- ... , A new report finds that health-care costs, quality ... depending on where you live. And compared with two years ... The findings come from a state-by-state scorecard on health care ...
... Oct. 8 LeVOCC, Inc. today announced that independent laboratory ... successfully destroys a strain of the H1N1 virus. Testing ... the H1N1 virus. This strain is an influenza A ... H1N1 strains. , The LeVOCC air purification system treats indoor ...
... Quality and Health Council Calls for Greater Surface Disinfection to Combat ... cough without covering your mouth while standing in the lunch line? ... morning bus? Nearly all Americans (96 percent) have seen you ... percent) say they are guilty themselves. , Even with heightened ...
... ... (STEMCELL), a Vancouver-based life sciences company, announces the launch of MethoCult® Express, an ... only 7 days of culture. , ... Vancouver, British Columbia (PRWEB) October 8, 2009 ...
... ... Products®, a leading direct-to-consumer provider of premium dietary supplements, announces the release of ... ... Purity Products ®, a leading direct-to-consumer provider of premium dietary supplements, announces the ...
Cached Medicine News:Health News:Elsevier's Health Sciences Division and Peking University Medical Press cooperate on book donation 2Health News:Health Care Varies From State to State 2Health News:Swine Flu (H1N1) Virus Destroyed by Innovative Air Treatment Technology 2Health News:Gross Germ-Spreading Behaviors Remain the Norm, Despite Flu Season Concerns 2Health News:Gross Germ-Spreading Behaviors Remain the Norm, Despite Flu Season Concerns 3Health News:STEMCELL Technologies Inc. Introduces MethoCult Express for Cord Blood Banks and Transplant Centers 2Health News:Purity Products Releases Their Brand New Mediterranean Diet Resveratrol Formula 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: